Generic Drug

Type: Keyphrase
Name: Generic Drug
First reported 23 mins ago - Updated 23 mins ago - 1 reports

Sustained Performance In The Future And Growth In The Top Line Make CVS A Buy

Summary The company’s healthy financial performance will be driven by retail segment’s and PBM segment’s growth. Continues to grow top-line numbers in competitive U.S. pharmacy market. Has been consistently sharing success with shareholders through ... [Published Seeking Alpha - 23 mins ago]
First reported 14 hours ago - Updated 14 hours ago - 1 reports

Venus Remedies up 17% on pact for selling anti-cancer drug

Aug 27, 2014 - 08:17 GMTVenus Remedies will be initially manufacturing the drug at the Venus Medicine Research Centre, its research unit, for assisting Teva in registrations.Shares of Venus Remedies jumped nearly 17 percent intraday Wednesday on signing ... [Published Mesothelioma News Today - 14 hours ago]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

US FDA approves Strides' anti-anxiety drug

Singapore: Indian drugmaker, Strides Arcolab, has announced that it has received approval from the United States Food and Drug Administration (US FDA) for its generic drug, Buspirone Hydrochloride tablets. The tablets are used for the treatment of anxiety ... [Published Bio Spectrum Asia - Aug 28 2014]
First reported Aug 27 2014 - Updated Aug 28 2014 - 1 reports

Sensex above 26,500; Tata Motors up 2%

Markets remained range bound at higher levels led by gains in shares of auto firms on talk that they will challenge the CCI order to pay penalty. Meanwhile, select bank and oil shares continued to trade firm after the first hour of trade.At 10:35AM, the ... [Published Business Standard India - Aug 27 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

Health care update - August 25‚ 2014

Administration Releases Updated Contraception Coverage Rules: On August 22nd, the Obama Administration proposed to extend a religious exemption to providing contraception coverage to closely held for-profit corporations. As we noted in an earlier update, ... [Published Lexology - Aug 28 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

The Opportunity Is Now For Kindred Biosciences

Summary KIN's first field test on Cerekin did not go successfully. The company's deep pipeline remains and a successful trial could be coming soon. All may not be lost for CereKin.As is often the case in the pharmaceutical sector, the biggest gains ... [Published Seeking Alpha - Aug 28 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Impact of GDUFA Performance Metrics on ANDA Approval Times

Generic drugmakers: You have until OCT. 1 to be GDUFA-ready. Help is at hand. Read this NOW .For generic drugmakers, Oct. 1 is Crunch Time — the date after which all your ANDA amendment and prior-approval supplement applications must meet new performance ... [Published FDA News - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Generic Drug Makers Tussle With International Standards Group

body: A nasty spat has broken out between the generic pharmaceutical industry and an international organization that develops widely accepted standards for developing prescription drugs. The International Generic Pharmaceutical Alliance, an umbrella group ... [Published AAPS Pharmceutica - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Mylan: Deeply Undervalued On Unwarranted Approval Concerns

Summary Mylan has a vast pipeline of generic drugs awaiting FDA approval. Concern about the timing of approvals has depressed the stock price. Patient investors are likely to see extraordinary returns in the next few years.Mylan (NASDAQ: MYL ) is a ... [Published Seeking Alpha - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Venus Remedies shares surge 15.5% on tie up with Israel's Teva

Shares of Venus Remedies surged over 15.5 per cent today as the company entered into a collaborative agreement with Israel-based generic drug maker Teva for selling an anti-cancer drug in the Canadian market.The pharma firm's scrip soared 14.77 per cent ... [Published Business Standard India - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 2 reports

FDA Puts Controls on Controlled Correspondence in the Agency’s Latest GDUFA Offering

By Kurt R. Karst –This blogger’s oldest child started middle school this past week.  Naturally, I was excited to get his impressions of the first day of school.  “Good” was his initial comment – a now all to familiar one-word tween response.  So I pressed ... [Published FDA Law Blog - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 2 reports

Venus Remedies surges after signing pact with Teva

Venus Remedies shares surged on Wednesday after entering into an agreement with Israel-based generic drug maker Teva for selling an anti-cancer drug in Canada.Shares of the company are trading at Rs 289.70, up Rs 32.1, or 12.46% at the Bombay Stock Exchange ... [Published MyIris - Aug 27 2014]

Quotes

"We remain optimistic that we can continue to gain specialty pharmacy share, as we work to develop innovative offerings that capitalize on our unique ability to optimize cost, quality and access."
In the August 14, 2014, Federal Register, FDA corrected a final rule entitled "Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements" that appeared in the June 10, 2014, Federal Register...
"The Indian economy likely accelerated in the second quarter of 2014. We expect GDP growth of 5.1%. Most parts of the economy are improving. Capital expenditure could surprise on the upside" Moody's Analytics said in a report
"The product will be manufactured at the company's oral dosage facility at Bangalore and marketed directly by Strides in the US Market" the company said in a statement

More Content

All (750) | News (559) | Reports (0) | Blogs (181) | Audio/Video (1) | Fact Sheets (3) | Press Releases (2)
sort by: Date | Relevance
Sustained Performance In The Future And Growth ... [Published Seeking Alpha - 23 mins ago]
Maria Chappelle-Nadal basks in controversy [Published STLtoday.com - 3 hours ago]
Pharmaceutical & Medical Device Regulatory Upda... [Published Jones Day - 12 hours ago]
June quarter results overview: What lies beneath? [Published Livemint.com - 13 hours ago]
Rite Aid’s Future Is Bright — Buy RAD Stock [Published InvestorPlace.com - 14 hours ago]
Venus Remedies up 17% on pact for selling anti-... [Published Mesothelioma News Today - 14 hours ago]
Guest Post - Not Quite a One-Two-Three Punch [Published Drug and Device Law - 18 hours ago]
Mylan CEO: Tax code handicaps and penalizes U.S... [Published Fortune - 21 hours ago]
Use It Or...... Else: Patent Non-Use as Abuse o... [Published McMillan - 22 hours ago]
Burger King’s Bonanza: The media finally wake u... [Published FOXNews.com - 23 hours ago]
Indian stock market daily morning report (Augus... [Published Stock Markets Review - Aug 28 2014]
US FDA approves Strides' anti-anxiety drug [Published Bio Spectrum Asia - Aug 28 2014]
Health care update - August 25‚ 2014 [Published Lexology - Aug 28 2014]
TWi Pharmaceuticals Receives US FDA Final Appro... [Published Reuters - Aug 28 2014]
Preparing the Supply Chain Pharma Needs [Published AT Kearney - Aug 28 2014]
The Opportunity Is Now For Kindred Biosciences [Published Seeking Alpha - Aug 28 2014]
Impact of GDUFA Performance Metrics on ANDA App... [Published FDA News - Aug 27 2014]
Generic Drug Makers Tussle With International S... [Published AAPS Pharmceutica - Aug 27 2014]
Why Aren't Rx Weight-Loss Drugs More in Demand? [Published Journal-News - Aug 27 2014]
Piramal to exit drug discovery business [Published Livemint.com - Aug 27 2014]
Mylan: Deeply Undervalued On Unwarranted Approv... [Published Seeking Alpha - Aug 27 2014]
New CEO takes the reins at Apotex [Published Chain Drug Review - Aug 27 2014]
Canara Bank to Split Stock; SBI Lowers Mortgage... [Published Ticker - Aug 27 2014]
Venus Remedies shares surge 15.5% on tie up wit... [Published Business Standard India - Aug 27 2014]
Nifty ends at record closing high ahead of Aug ... [Published Business Standard India - Aug 27 2014]
Hospitality shares rally [Published Business Standard India - Aug 27 2014]
FDA Puts Controls on Controlled Correspondence ... [Published FDA Law Blog - Aug 27 2014]
US FDA posts draft guidance on correspondence r... [Published Express Pharma - Aug 27 2014]
Venus Remedies surges after signing pact with Teva [Published MyIris - Aug 27 2014]
Venus Remedies jumps on entering into collabora... [Published Arihant Capital - Aug 27 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Guest Post - Not Quite a One-Two-Three Punch [Published Drug and Device Law - 18 hours ago]
What follows is another of our occasional guest posts, this time by fellow Reed Smith attorney Danielle Devens .  As always with our guest posts, the author gets all the credit, and any blame, for the contents of his/her work.******************            ...
FDA Puts Controls on Controlled Correspondence ... [Published FDA Law Blog - Aug 27 2014]
By Kurt R. Karst –This blogger’s oldest child started middle school this past week.  Naturally, I was excited to get his impressions of the first day of school.  “Good” was his initial comment – a now all to familiar one-word tween response.  So I pressed ...
Transforming Cancer Care and the Role of Paymen... [Published Brookings Latest From Brookings - Aug 26 2014]
Living With Cancer: Vicky's Story Vicky Bolton is a 58 year-old medical legal coordinator who lives in Albuquerque, New Mexico. A widower of 20 years, Vicki has three children and nine grandchildren. She is also a Stage 4 adenocarcinoma lung cancer ...
Conference on Paragraph IV Litigation [Published Patent Docs - Aug 23 2014]
Momentum will be holding its 2nd Congress on PIV Litigation on October 29-30, 2014 in Philadelphia, PA. The conference will offer presentations on the following topics:•Key Takeaways for Brand and Generic Drug Manufacturers from Recent Case Law•Are Your ...
Dreaming The Impossible Dream [Published Drug and Device Law - Aug 22 2014]
A short history of recent implied preemption “impossibility” decisions:  (1) In Wyeth v. Levine, 555 U.S. 555 (2009), impossibility preemption did not apply to innovator prescription drugs because simultaneous compliance with FDA and state tort law labeling ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Lindt Buys A Big Box Of Chocolates [Published Wall Street Journal What's News - Jul 14 2014]
1

Press Releases

sort by: Date | Relevance
IGI Laboratories Announces Second Quarter 2014 ... [Published Financial Services - Jul 24 2014]
New Analysis Finds $5.4 Billion In Annual Lost ... [Published Financial Services - Jul 23 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.